IMMURON LIMITED (IMRN)

Every figure this model derived for IMRN, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2023-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 7,067 PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities 2022-12-31
cash 2,721,574 CashAndCashEquivalents 2024-06-30
current assets 18,946,639 CurrentAssets 2023-12-31
current liabilities 2,223,943 CurrentLiabilities 2023-12-31
equity 17,526,515 Equity 2023-12-31
interest expense 4,007 FinanceCosts 2023-12-31
ocf -2,003,836 CashFlowsFromUsedInOperatingActivities 2023-12-31
revenue 2,355,580 RevenueFromContractsWithCustomers 2023-12-31
sbc 8,921 AdjustmentsForSharebasedPayments 2023-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up IMRN on one particular measure came for.

RatioValue
cash operating margin-85.38
current ratio8.52
current ratio reported8.52
fcf margin-85.37
interest cover-504.12
operating margin-85.76
owner earnings margin-85.75
revenue growth303.6
revenue growth per share303.6
rule of 40217.84
sbc pct revenue0.38

What to be careful about

What this model itself distrusts about IMRN's figures. Written by the derivation as it ran, not added afterwards.